Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer’s disease patients: A CSF and FDG PET study
Agostino Chiaravalloti, Gaetano Barbagallo, Maria Ricci, et al.
Brain Research (2017) Vol. 1678, pp. 116-122
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Biomarkers for tau pathology
Michael Schöll, Anne Maaß, Niklas Mattsson, et al.
Molecular and Cellular Neuroscience (2018) Vol. 97, pp. 18-33
Open Access | Times Cited: 192
Advances and considerations in AD tau-targeted immunotherapy
Alice Bittar, Nemil Bhatt, Rakez Kayed
Neurobiology of Disease (2019) Vol. 134, pp. 104707-104707
Open Access | Times Cited: 84
Brain metabolism in Alzheimer’s disease: biological mechanisms of exercise
Longfei Xu, Ran Liu, Yingkai Qin, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer’s Disease
Tommaso Schirinzi, Francesco Di Lorenzo, Giulia Maria Sancesario, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. 2, pp. 525-532
Closed Access | Times Cited: 55
From beta amyloid to altered proteostasis in Alzheimer’s disease
Amalia C. Bruni, Livia Bernardi, Carlo Gabelli
Ageing Research Reviews (2020) Vol. 64, pp. 101126-101126
Closed Access | Times Cited: 41
Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice
Chetan Thingore, Viplav Kshirsagar, Archana Juvekar
Metabolic Brain Disease (2020) Vol. 36, Iss. 2, pp. 299-313
Closed Access | Times Cited: 39
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome
José Enrique Arriola‐Infante, Alejandra O. Morcillo‐Nieto, Sára E. Zsadanyi, et al.
Annals of Neurology (2025)
Closed Access
Traumatic brain injury and the pathways to cerebral tau accumulation
William P. Flavin, Helia Hosseini, Jeffrey W. Ruberti, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 10
Impairments in Brain Bioenergetics in Aging and Tau Pathology: A Chicken and Egg Situation?
Amandine Grimm
Cells (2021) Vol. 10, Iss. 10, pp. 2531-2531
Open Access | Times Cited: 21
Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer’s disease: an exploratory study of 18F-FDG-PET
Qi Zhang, Chunqiu Fan, Luyao Wang, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 1407-1420
Open Access | Times Cited: 8
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
Maria Ricci, Andrea Cimini, Riccardo Camedda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13002-13002
Open Access | Times Cited: 20
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia
Beatrice Orso, Luigi Lorenzini, Dario Arnaldi, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 544-544
Open Access | Times Cited: 13
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Caterina Motta, Martina Gaia Di Donna, Chiara Giuseppina Bonomi, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Nuclear Medicine and Anatomic Pathology in Personalized Medicine: A Challenging Alliance
Nicoletta Urbano, Manuel Scimeca, Elena Bonanno, et al.
Personalized Medicine (2018) Vol. 15, Iss. 6, pp. 457-459
Closed Access | Times Cited: 19
Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients?
Agostino Chiaravalloti, Gaetano Barbagallo, Alessandro Martorana, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 46, Iss. 9, pp. 1796-1805
Closed Access | Times Cited: 14
Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain
Agostino Chiaravalloti, Anna Elisa Castellano, Maria Ricci, et al.
Molecular Imaging and Biology (2018) Vol. 20, Iss. 4, pp. 659-666
Closed Access | Times Cited: 13
Biomarkers for Neurodegenerative Diseases
Mai Mohamed Abdelmoaty, Eugene Y. C. Lu, Emma G. Foster
NeuroImmune Pharmacology and Therapeutics (2024), pp. 777-805
Closed Access | Times Cited: 1
The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer’s disease
Alice Jaillard, Matthieu Vanhoutte, Aurélien Maureille, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2018) Vol. 46, Iss. 2, pp. 324-333
Closed Access | Times Cited: 7
The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer’s Disease
Agostino Chiaravalloti, Maria Ricci, Daniele Di Biagio, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 2, pp. 25-25
Open Access | Times Cited: 7
Plasma tau predicts cerebral vulnerability in aging
José L. Cantero, Mercedes Atienza, Jaime Ramos‐Cejudo, et al.
Aging (2020) Vol. 12, Iss. 21, pp. 21004-21022
Open Access | Times Cited: 7
Correlation of [18F]florbetaben textural features and age of onset of Alzheimer’s disease: a principal components analysis approach
Jing Li, Emanuele Antonecchia, Marco Camerlenghi, et al.
EJNMMI Research (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
The development of new method to differentiate between Dementia with Lewy bodies and Alzheimer’s disease by cerebral perfusion SPECT-comparison to CIScore
Gaku Honda, Shigeki Nagamachi, Masanari Nonokuma, et al.
Japanese Journal of Radiology (2020) Vol. 39, Iss. 2, pp. 198-205
Closed Access | Times Cited: 6
Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study
Chiara Giuseppina Bonomi, Agostino Chiaravalloti, Riccardo Camedda, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 725-725
Open Access | Times Cited: 2
Brain 18F‐FDG‐PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's disease
Katharina Woyk, Carsten Oliver Sahlmann, Niels Hansen, et al.
Journal of Neuroimaging (2022) Vol. 33, Iss. 2, pp. 256-268
Open Access | Times Cited: 4
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease
Maria Ricci, Agostino Chiaravalloti, Alessandro Martorana, et al.
Annals of Nuclear Medicine (2020) Vol. 34, Iss. 4, pp. 254-262
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top